FR2196162B1 - - Google Patents

Info

Publication number: FR2196162B1
Authority: FR; France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

FR7329860A

Other versions

FR2196162A1 (fr

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sumitomo Chemical Co Ltd

Original Assignee

Sumitomo Chemical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-08-17

Filing date

1973-08-16

Publication date

1977-01-28

1972-08-17 Priority claimed from JP47082574A external-priority patent/JPS5238559B2/ja

1973-04-05 Priority claimed from JP48039354A external-priority patent/JPS49125359A/ja

1973-08-16 Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd

1974-03-15 Publication of FR2196162A1 publication Critical patent/FR2196162A1/fr

1977-01-28 Application granted granted Critical

1977-01-28 Publication of FR2196162B1 publication Critical patent/FR2196162B1/fr

Status Expired legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

FR7329860A 1972-08-17 1973-08-16 Expired FR2196162B1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP47082574A JPS5238559B2 (fr)	1972-08-17	1972-08-17
JP48039354A JPS49125359A (fr)	1973-04-05	1973-04-05
ZA00741280A ZA741280B (en)	1972-08-17	1974-02-26	Thiazole derivatives

Publications (2)

Publication Number	Publication Date
FR2196162A1 FR2196162A1 (fr)	1974-03-15
FR2196162B1 true FR2196162B1 (fr)	1977-01-28

Family

ID=27290112

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR7329860A Expired FR2196162B1 (fr)	1972-08-17	1973-08-16

Country Status (10)

Country	Link
US (1)	US3932400A (fr)
CA (1)	CA991640A (fr)
CH (1)	CH581640A5 (fr)
DE (1)	DE2341753C2 (fr)
DK (1)	DK149893C (fr)
FR (1)	FR2196162B1 (fr)
GB (1)	GB1435139A (fr)
NL (1)	NL179733C (fr)
SE (1)	SE421615B (fr)
ZA (1)	ZA741280B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4001421A (en) *	1971-10-27	1977-01-04	Syntex (U.S.A.) Inc.	Thiazole cardiovascular agents
US4119718A (en) *	1977-05-02	1978-10-10	Merck & Co., Inc.	3-Amino-2-oxy-propoxy-substituted isothiazoles
US4259341A (en) *	1977-06-01	1981-03-31	Merck & Co., Inc.	Di- and tri-substituted thiazoles
US4260609A (en) *	1977-06-01	1981-04-07	Merck & Co., Inc.	Di- and tri- substituted thiazoles
US4396625A (en) *	1980-05-13	1983-08-02	Sumitomo Chemical Company, Limited	Treatment of glaucoma or ocular hypertension and ophthalmic composition
US4670450A (en) *	1985-11-13	1987-06-02	Merrell Dow Pharmaceuticals Inc.	Cardiotonic thiazolones
BR0313593A (pt)	2002-08-19	2005-07-12	Pfizer Prod Inc	Terapia de combinação para doenças hiperproliferativas
OA13174A (en) *	2003-05-30	2006-12-13	Ranbaxy Lab Ltd	Substituted pyrrole derivatives and their use as HMG-Co inhibitors.
US20050037063A1 (en) *	2003-07-21	2005-02-17	Bolton Anthony E.	Combined therapies
US20060063803A1 (en) *	2004-09-23	2006-03-23	Pfizer Inc	4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
EP1819681B1 (fr) *	2004-11-23	2009-08-12	Warner-Lambert Company LLC	Derives d'acide 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoique comme inhibiteurs de hmg co-a reductase pour le traitement de l'hyperlipidemie
GT200600381A (es)	2005-08-25	2007-03-28		Compuestos organicos
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
WO2007054896A1 (fr) *	2005-11-08	2007-05-18	Ranbaxy Laboratories Limited	Procede de preparation de sel hemicalcique d’acide (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxymethylphenylamino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoique
WO2007086980A2 (fr) *	2005-11-10	2007-08-02	Duke University	Méthodes permettant de déterminer le risque de développer une coronaropathie
US7888376B2 (en)	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
ES2389062T3 (es) *	2006-01-18	2012-10-22	Amgen, Inc	Compuestos de tiazol como inhibidores de proteína cinasa B (PKB)
US8383660B2 (en)	2006-03-10	2013-02-26	Pfizer Inc.	Dibenzyl amine compounds and derivatives
US7919506B2 (en)	2006-03-10	2011-04-05	Pfizer Inc.	Dibenzyl amine compounds and derivatives
WO2008020314A2 (fr) *	2006-03-14	2008-02-21	Ranbaxy Laboratories Limited	Formulations de dosage stabilisantes à base de statine
WO2008010087A2 (fr) *	2006-07-14	2008-01-24	Ranbaxy Laboratories Limited	FORMES POLYMORPHES D'UN INHIBITEUR DE LA HMG-CoA-RÉDUCTASE ET LEURS UTILISATIONS
CN101663262B (zh)	2006-12-01	2014-03-26	百时美施贵宝公司	用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
AU2008276512A1 (en) *	2007-07-17	2009-01-22	Amgen Inc.	Thiadiazole modulators of PKB
JP2016516804A (ja)	2013-04-17	2016-06-09	ファイザー・インク	心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
WO2016055901A1 (fr)	2014-10-08	2016-04-14	Pfizer Inc.	Composés d'amide substitué
CN104530033B (zh) *	2014-12-26	2017-07-07	江西百神药业股份有限公司	一种盐酸阿罗洛尔的制备工艺新方法
CN105646472A (zh) *	2016-02-29	2016-06-08	山东齐都药业有限公司	一种盐酸阿罗洛尔的制备方法
AU2020209215B2 (en)	2019-01-18	2023-02-02	Astrazeneca Ab	PCSK9 inhibitors and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA599475A (en) *		1960-06-07	W. Harman Marion	Aminoethylthiazoles
US2221147A (en) *	1938-11-18	1940-11-12	Goodrich Co B F	Preparation of aminated esters of sulphydryl compounds
US3228952A (en) *	1962-06-27	1966-01-11	Dow Chemical Co	Thiazole thioethers
US3158623A (en) *	1963-03-01	1964-11-24	Abbott Lab	5-nitro-2-furylthioamide
BE790569A (fr) *	1971-10-27	1973-04-26	Syntex Corp	Agents cardiovasculaires a base de thiazoles

1973
- 1973-08-14 GB GB3950573A patent/GB1435139A/en not_active Expired
- 1973-08-15 NL NLAANVRAGE7311248,A patent/NL179733C/xx not_active IP Right Cessation
- 1973-08-16 US US05/389,517 patent/US3932400A/en not_active Expired - Lifetime
- 1973-08-16 CH CH1182373A patent/CH581640A5/xx not_active IP Right Cessation
- 1973-08-16 DK DK452273A patent/DK149893C/da not_active IP Right Cessation
- 1973-08-16 CA CA178,970A patent/CA991640A/en not_active Expired
- 1973-08-16 FR FR7329860A patent/FR2196162B1/fr not_active Expired
- 1973-08-16 SE SE7311181A patent/SE421615B/xx unknown
- 1973-08-17 DE DE2341753A patent/DE2341753C2/de not_active Expired
1974
- 1974-02-26 ZA ZA00741280A patent/ZA741280B/xx unknown

Also Published As

Publication number	Publication date
FR2196162A1 (fr)	1974-03-15
NL179733B (nl)	1986-06-02
NL179733C (nl)	1986-11-03
AU5928173A (en)	1975-02-20
DK149893B (da)	1986-10-20
SE421615B (sv)	1982-01-18
GB1435139A (en)	1976-05-12
NL7311248A (fr)	1974-02-19
US3932400A (en)	1976-01-13
DK149893C (da)	1987-04-21
CH581640A5 (fr)	1976-11-15
ZA741280B (en)	1975-03-26
DE2341753A1 (de)	1974-02-21
DE2341753C2 (de)	1982-12-09
CA991640A (en)	1976-06-22

Publication	Publication Date	Title
FR2196162B1 (fr)	1977-01-28
JPS4959843A (fr)	1974-06-11
JPS4912938A (fr)	1974-02-04
FR2197508B1 (fr)	1980-03-14
FR2195445B1 (fr)	1976-10-22
JPS5513991B2 (fr)	1980-04-12
JPS521446B2 (fr)	1977-01-14
JPS497517U (fr)	1974-01-22
JPS48114685U (fr)	1973-12-27
JPS4969544U (fr)	1974-06-17
JPS4911540U (fr)	1974-01-31
JPS5350403Y2 (fr)	1978-12-02
JPS4826881Y1 (fr)	1973-08-07
JPS48100480A (fr)	1973-12-18
CH582135A5 (fr)	1976-11-30
CH575507A5 (fr)	1976-05-14
CH584252A5 (fr)	1977-01-31
CH583286A5 (fr)	1976-12-31
CH582797A5 (fr)	1976-12-15
CH582512A5 (fr)	1976-12-15
CH582154A5 (fr)	1976-11-30
CH582150A5 (fr)	1976-11-30
DD100158A1 (fr)	1973-09-12
CH581698A5 (fr)	1976-11-15
CH581403A5 (fr)	1976-10-29